What we promise?
Product | Amiloride 15N3 |
---|---|
CAT No. | CS-O-06400 |
CAS No. | 1217169-93-1 |
Status | Available for Dispatch by 27-Sep-2023 |
Category | Stable Isotopes |
Hazardous | This is not a Hazardous Compound |
Purity | Not less than 90% |
Controlled | No |
Amiloride 15N3 is a medication that is primarily used to treat high blood pressure and congestive heart failure. It belongs to a class of drugs known as potassium-sparing diuretics. Amiloride 15N3 works by blocking the reabsorption of sodium ions in the kidneys, which leads to increased excretion of sodium and water from the body. This, in turn, reduces the amount of fluid in the blood vessels and helps to lower blood pressure. The chemical formula of Amiloride 15N3 is C6H8ClN7O, and it is a nitrogen-15 labeled version of the drug amiloride. It is an odorless, white crystalline powder that is soluble in water. The molecular weight of Amiloride 15N3 is 236.68 g/mol. Amiloride 15N3 is typically taken orally once or twice a day, with or without food. The dosage will depend on the individual's medical condition and response to treatment. Patients should not exceed the prescribed dose or take the medication for longer than recommended. Like all medications, Amiloride 15N3 may cause side effects, such as dizziness, headache, nausea, vomiting, and diarrhea. Patients should contact their healthcare provider if they experience any severe or persistent side effects. In conclusion, Amiloride 15N3 is a medication that is widely used for the treatment of high blood pressure and congestive heart failure. It is a potassium-sparing diuretic that works by blocking the reabsorption of sodium ions in the kidneys. While it can be an effective treatment, patients should always follow the dosage instructions provided by their healthcare provider and report any side effects they experience.
Packing | Product will be supplied in Vials, in certain conditions we also use 'Septa Vials' |
---|---|
Controlled | No |
Parent API | Amiloride |
Hazardous | No |
General Information | Use proper personal protective equipment |
---|---|
Handling | Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. |
Engineering Control | Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels. |
Clothing | Wear appropriate protective clothing to minimize contact with skin. |
Skin | Wear appropriate protective gloves and clothing to prevent skin exposure. |
Eyes | Wear safety glasses and chemical goggles if splashing is possible. |
Inhalation | Remove from exposure and move to fresh air immediately. |
![]() |
Amiloride 15N3 | www.clearsynth.com |
CAT : CS-O-06400 | BATCH : CSC-WWW0757 |
|
MF: -- CAS: 1217169-93-1 Date of Anaysis: 22-Aug-2023 Retest Date: 22-Jun-2026 |
MW: --
Store at refrigerator (2-8C) |
Qty: 60 MG |
Only for R & D and Analytical purpose, Not for Human Consumption. |
Stable Isotopes
Secondary Standards
EP Standards
API Standards
Fine Chemicals
Impurities
USP Standards
Impurities
Secondary Standards
Secondary Standards
Stable Isotopes
Intermediates
Impurities
Impurities
Intermediates
Need a Quote?
Your email address will not be published. Required fields are marked *